VOGLIMARK GM1 TAB
Product Description
VOGLIMARK GM1 TAB tablet contains glimepiride + metformin + voglibose, a triple-combination oral anti-diabetic medicine used in adults with type 2 diabetes mellitus when diet, exercise, and dual-drug therapy do not provide adequate control. It combines a sulfonylurea, a biguanide, and an alpha-glucosidase inhibitor to provide three-way glucose control—one helps the pancreas release more insulin, another reduces glucose production in the liver and improves insulin sensitivity, while the third slows carbohydrate absorption from the intestine to reduce post-meal sugar spikes. VOGLIMARK GM1 TAB tablet is commonly available in strengths such as 1 mg/500 mg/0.2 mg and 1 mg/500 mg/0.3 mg SR, with the VOGLIMARK GM1 TAB dosage adjusted according to HbA1c, fasting glucose, meal-time sugar spikes, and kidney function.
Pharmacist Note
Take VOGLIMARK GM1 TAB tablet with the first main meal of the day to reduce stomach upset and improve post-meal sugar control. Do not skip meals after taking it, because the chance of low blood sugar increases. Keep glucose tablets, sugar candy, or fruit juice nearby in case you develop sweating, tremors, sudden hunger, or weakness.
Uses & Benefits
used to treat type 2 diabetes mellitus in adults
Advanced Type 2 Diabetes Control: [{product_name}] tablet helps control blood sugar in adults whose diabetes is not adequately managed with one or two medicines alone. Better sugar control supports improved HbA1c and lowers the long-term risk of diabetic kidney disease, nerve damage, and eye complications.
Controls Post-Meal Sugar Spikes: [{product_name}] tablet is especially useful for reducing sharp blood sugar rises after meals. By slowing carbohydrate breakdown in the gut, it helps maintain steadier glucose levels through the day.
Triple Mechanism Action: [{product_name}] tablet works through three complementary pathways for stronger glucose control. It boosts insulin release, reduces liver glucose output, and slows intestinal glucose absorption, making it effective for both fasting and post-meal sugars.
Convenient Fixed-Dose Therapy: By combining three anti-diabetic medicines into one tablet, [{product_name}] tablet reduces pill burden and improves convenience. This may improve adherence in patients who need long-term diabetes management.
Side Effects
common:
moderate:
serious:
How to Use & Safety Advice
[{"icon":"dosage","title":"Dosage","description":"The [{product_name}] dosage is individualized based on fasting sugar, post-meal sugar, and HbA1c response. Doctors may start with a lower strength and increase gradually for better tolerance and safer glucose control."},{"icon":"timing","title":"Timing","description":"Take [{product_name}] tablet with breakfast or the first major meal of the day. Swallow it whole with water, especially if it is a sustained-release form, and do not crush or chew unless advised."},{"icon":"limit","title":"Limit","description":"Do not exceed the prescribed [{product_name}] dosage, even if blood sugar is temporarily high. Taking extra tablets can cause severe low blood sugar, stomach side effects, or serious metabolic complications.\n"},{"icon":"consistency","title":"Consistency","description":"Take [{product_name}] tablet at the same time every day for steady glucose control. Irregular timing can worsen sugar fluctuations, especially after meals."}]
[{"icon": "pregnancy", "title": "Pregnancy", "description": "[{product_name}] tablet should only be used during pregnancy if specifically prescribed by a doctor. Insulin is often preferred for tighter and safer blood sugar control in pregnancy."}, {"icon": "alcohol", "title": "Alcohol", "description": "Avoid alcohol while taking [{product_name}] tablet because it can increase the risk of low blood sugar and metformin-related lactic acidosis. Even occasional intake should be discussed with your doctor."}, {"icon": "driving", "title": "Driving", "description": "[{product_name}] tablet may cause sweating, dizziness, blurred vision, or shakiness if blood sugar drops too low. Check glucose before driving and avoid long trips if symptoms occur."}, {"icon": "kidney", "title": "Kidney", "description": "Patients with kidney disease may need careful dose adjustment because the metformin component can accumulate and increase side effects. Regular renal function monitoring is important."}, {"icon": "elderly", "title": "Elderly", "description": "Older adults may be more sensitive to [{product_name}] side effects such as hypoglycemia and constipation. Lower starting doses and closer monitoring are often recommended."}, {"icon": "children", "title": "Children", "description": "[{product_name}] tablet is generally not routinely recommended in children unless prescribed by a specialist. Safety and dosing depend on age, body weight, and diabetes severity."}]
Details
VOGLIMARK GM1 TAB tablet contains glimepiride + metformin + voglibose, a triple-combination oral anti-diabetic medicine used in adults with type 2 diabetes mellitus when diet, exercise, and dual-drug therapy do not provide adequate control. It combines a sulfonylurea, a biguanide, and an alpha-glucosidase inhibitor to provide three-way glucose controlâone helps the pancreas release more insulin, another reduces glucose production in the liver and improves insulin sensitivity, while the third slows carbohydrate absorption from the intestine to reduce post-meal sugar spikes. VOGLIMARK GM1 TAB tablet is commonly available in strengths such as 1 mg/500 mg/0.2 mg and 1 mg/500 mg/0.3 mg SR, with the VOGLIMARK GM1 TAB dosage adjusted according to HbA1c, fasting glucose, meal-time sugar spikes, and kidney function.